| HOME >> MEDICINE >> TECHNOLOGY |
Nine months ended September 30,2009
2010
2009
2010US$
US$
US$
US$(unaudited)
(unaudited)
(unaudited)
(unaudited)Non-GAAP net income37,376
39,538
105,726
125,570Non-GAAP net margin
24.7%
23.5%
23.7%
25.5%Amortization of acquired intangible assets
(2,135)
(1,745)
(6,484)
(5,745)Deferred tax impact related to acquired intangible assets
90
33
288
174Realignment costs — post acquisition
(1,030)
-
(1,261)
-Income from early termination of contract
11,757
-
11,757
-Share-based compensation
(2,636)
(1,888)
(8,249)
(5,582)GAAP net income
43,422
35,938
101,777
114,417GAAP net margin
28.7%
21.4%
22.9%
23.2%Non-GAAP income per share - basic
0.34
0.35
0.98
1.11Non-GAAP income per share - diluted
0.33
0.34
0.94
1.07GAAP income per share - basic
0.40
0.31
0.94
1.01GAAP income per share - diluted
0.38
0.30
0.90
0.97 Shares used in computation of: Basic earnings per share
108,845,481
114,489,052
108,337,457
113,351,832 Diluted earnings per share
113,374,202
117,884,600
112,671,743
117,396,900Non-GAAP operating income40,028
42,382
118,617
129,518Non-GAAP operating margin
26.5%
25.2%
26.6%
26.3%Amortization of acqu
'/>"/>
| SOURCE Mindray Medical International Limited Copyright©2010 PR Newswire. All rights reserved |